LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Glaukos (NYSE:GKOS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.

Which has preferable valuation and earnings, LMAT or GKOS?

LeMaitre Vascular has higher earnings, but lower revenue than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$193.48M	11.51	$30.10M	$1.83	54.13
Glaukos	$314.71M	27.44	-$134.66M	-$3.02	-51.85

Which has more volatility and risk, LMAT or GKOS?

LeMaitre Vascular has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

Is LMAT or GKOS more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Glaukos' net margin of -42.43%. LeMaitre Vascular's return on equity of 13.15% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	19.40%	13.15%	11.47%
Glaukos	-42.43%	-18.99%	-11.47%

Does the MarketBeat Community prefer LMAT or GKOS?

LeMaitre Vascular received 68 more outperform votes than Glaukos when rated by MarketBeat users. Likewise, 70.70% of users gave LeMaitre Vascular an outperform vote while only 64.83% of users gave Glaukos an outperform vote.

Company	Underperform	Outperform
LeMaitre Vascular	Outperform Votes 514 70.70%	Underperform Votes 213 29.30%
Glaukos	Outperform Votes 446 64.83%	Underperform Votes 242 35.17%

Does the media prefer LMAT or GKOS?

In the previous week, LeMaitre Vascular and LeMaitre Vascular both had 5 articles in the media. LeMaitre Vascular's average media sentiment score of 0.77 beat Glaukos' score of 0.59 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Glaukos	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in LMAT or GKOS?

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 10.8% of LeMaitre Vascular shares are held by insiders. Comparatively, 6.4% of Glaukos shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts rate LMAT or GKOS?

LeMaitre Vascular presently has a consensus target price of $94.57, suggesting a potential downside of 4.53%. Glaukos has a consensus target price of $147.75, suggesting a potential downside of 5.65%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, equities analysts clearly believe LeMaitre Vascular is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
Glaukos	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85

Summary

LeMaitre Vascular beats Glaukos on 11 of the 16 factors compared between the two stocks.